Eleftherios Diamandis
Eleftherios Diamandis | |
|---|---|
| Born | Eleftherios Phedias Diamandis October 8, 1952 |
| Citizenship | Canada Cyprus |
| Education | University of Athens University of Toronto |
| Known for | Research on cancer biomarkers |
| Spouse | Anastasia |
| Children | 2 |
| Scientific career | |
| Fields | Clinical chemistry |
| Institutions | University of Toronto |
Eleftherios Phedias Diamandis (born October 8, 1952)[1] is a Greek Cypriot-Canadian biochemist who specializes in clinical chemistry. He is Professor & Head of Clinical Biochemistry in the Department of Laboratory Medicine and Pathobiology at the University of Toronto in Toronto, Ontario, Canada. He is also Division Head of Clinical Biochemistry at Mount Sinai Hospital and Biochemist-in-Chief at the University Health Network, both of which are also located in Toronto.[2]
Honors and awards
[edit]Diamandis is a member of the Academy of Athens and the Royal Society of Canada. He is also a fellow of the American Association for the Advancement of Science, the Canadian Academy of Health Sciences, and the Royal College of Physicians and Surgeons of Canada. From the American Association for Clinical Chemistry, he has received the Morton K. Schwartz Award for Significant Contributions in Cancer Research Diagnostics, among other awards; he is also a member of the Association's Hall of Fame.[2][3]
Theranos
[edit]In May 2015, Diamandis performed a deep investigation into claims of health technology company Theranos and concluded in a report that "most of the company's claims are exaggerated."[4][5] This insight from Diamandis triggered John Carreyrou to further investigate the claims that had been made by Theranos. At the time, Theranos was widely considered a reliable and functional analysis company.[4]
References
[edit]- ^ "Eleftherios P. Diamandis CV" (PDF). University of Toronto. 2017-04-28. Retrieved 2019-03-26.
- ^ a b "Eleftherios Diamandis". University of Toronto. Archived from the original on 2019-03-26. Retrieved 2019-03-26.
- ^ "Eleftherios P. Diamandis, MD, PhD". Hall of Fame. American Association for Clinical Chemistry. Retrieved 2019-03-26.
- ^ a b Diamandis, E. P. (2015). "Theranos phenomenon: promises and fallacies". Clinical Chemistry and Laboratory Medicine. 53 (7): 989–993. doi:10.1515/cclm-2015-0356. PMID 26030792. S2CID 13822780.
- ^ Friedman, Lauren F.; Loria, Kevin. "A scientist just raised 4 serious questions about the blood test that made Elizabeth Holmes a billionaire". Business Insider. Retrieved June 26, 2015.
Further reading
[edit]- Landau, M. (2013-05-01). "Eleftherios P. Diamandis". Clinical Chemistry. 59 (5): 850–852. doi:10.1373/clinchem.2012.195446. ISSN 0009-9147. PMID 23624897.
External links
[edit]- Faculty page Archived 2019-03-26 at the Wayback Machine
- Eleftherios Diamandis publications indexed by Google Scholar
| Key people |
|  |
|---|---|---|
| Creditors, investors, and partners | ||
| Investigation | ||
| Other | ||
| Board members | ||
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
 | This article about a biochemist is a stub. You can help Wikipedia by expanding it. |
- Cypriot medical researchers
- Living people
- Cypriot emigrants to Canada
- Canadian biochemists
- Academic staff of the University of Toronto
- University of Toronto alumni
- People from Limassol
- Fellows of the American Association for the Advancement of Science
- Fellows of the Canadian Academy of Health Sciences
- Fellows of the Royal Society of Canada
- Members of the Academy of Athens (modern)
- Clinical chemists
- Cancer researchers
- Fellows of the Royal College of Physicians and Surgeons of Canada
- National and Kapodistrian University of Athens alumni
- 1952 births
- Biochemist stubs